5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.43▲ | 0.42▲ | 0.42▲ | 0.43▲ | 0.41▲ |
MA10 | 0.42▲ | 0.42▲ | 0.42▲ | 0.41▲ | 0.45▼ |
MA20 | 0.41▲ | 0.41▲ | 0.41▲ | 0.42▲ | 0.48▼ |
MA50 | 0.42▲ | 0.42▲ | 0.42▲ | 0.45▼ | 0.63▼ |
MA100 | 0.42▲ | 0.43▼ | 0.44▼ | 0.48▼ | N/A |
MA200 | 0.45▼ | 0.45▼ | 0.46▼ | 0.58▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.003▲ | 0.003▲ | 0.003▲ | 0.005▲ | 0.003▲ |
RSI | 57.545▲ | 56.449▲ | 57.153▲ | 50.480▲ | 40.145▼ |
STOCH | 60.013 | 72.503 | 83.866▲ | 70.907 | 19.965▼ |
WILL %R | -24.506▲ | -19.375▲ | -12.551▲ | -31.348 | -87.805▼ |
CCI | 85.497 | 97.467 | 112.558▲ | 67.703 | -91.561 |
▼ GAP | $TLPH Open Gap Down %2 | Set Alert |
Saturday, August 16, 2025 05:12 AM
Q2 2025 Earnings Call Transcript August 14, 2025 Talphera, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.12. Operator: Welcome to the Talphera Second Quarter 2025 ...
|
Friday, August 15, 2025 12:37 AM
Talphera Inc (TLPH) reports reduced cash operating expenses and accelerated patient enrollment, despite facing supply chain challenges and financial constraints.
|
Thursday, August 14, 2025 06:11 PM
Discover Talphera, Inc.'s Q2 2025 earnings call insights! Explore accelerated NEPHRO study progress, cost-efficient strategies, & operational milestones.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 0.42 | 0.44 | 0.41 | 0.43 | 212,600 |
14/08/25 | 0.435 | 0.4399 | 0.41 | 0.4296 | 119,975 |
13/08/25 | 0.415 | 0.44 | 0.4071 | 0.4325 | 152,713 |
12/08/25 | 0.42 | 0.43 | 0.41 | 0.42 | 67,000 |
11/08/25 | 0.41 | 0.43 | 0.40 | 0.42 | 168,400 |
08/08/25 | 0.39 | 0.41 | 0.39 | 0.41 | 146,900 |
07/08/25 | 0.401 | 0.4044 | 0.3862 | 0.3915 | 95,556 |
06/08/25 | 0.40 | 0.41 | 0.39 | 0.40 | 91,300 |
05/08/25 | 0.407 | 0.4076 | 0.391 | 0.393 | 91,668 |
04/08/25 | 0.41 | 0.41 | 0.40 | 0.40 | 19,500 |
|
|
||||
|
|
||||
|
|